Drug · DIN 02264188
TEVA-RISPERIDONE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since October 26, 2022; first marketed July 5, 2006.
- Drug Identification Number (DIN)
- 02264188
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 26, 2022: NOC 29316Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
- November 28, 2012: NOC 13910Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- July 5, 2006: NOC 8113Abbreviated New Drug Submission (ANDS)
Other DINs named TEVA-RISPERIDONE
- DIN 02264196 · Marketed
- DIN 02264218 · Marketed
- DIN 02264226 · Marketed
- DIN 02264234 · Marketed
- DIN 02282690 · Marketed